Alzheimer’s Care: Why Earlier Information Matters More Than Ever
For years, much of Alzheimer’s care has been organized around responding to what is already happening. A change in memory leads to an appointment. A new behavioral symptom creates another concern. A fall, medication issue, or sudden change in daily functioning can turn into a crisis that requires immediate attention.
That model is beginning to change.
The most important developments in Alzheimer’s care are not simply about adding more technology. They are about giving families and clinicians better information earlier, so they have more time to understand what is happening, make informed decisions, and prepare for what may come next.
Blood-based biomarkers are one example of this shift. In 2025, the FDA cleared the first blood test to aid in detecting amyloid pathology associated with Alzheimer’s in adults 55 and older who have signs and symptoms of cognitive decline. The test is not intended to be a stand-alone screening tool or diagnosis, but it represents an important step toward making Alzheimer’s assessment less invasive and potentially more accessible.
At the same time, research is expanding around digital health, telehealth, and other ways of collecting information about how people function in everyday life. NIA-supported research is examining digital phenotyping, health information technology, telehealth, and technology-enabled support for both people living with dementia and their care partners.
The opportunity is not to predict every change perfectly. It is to give people better information early enough for that information to be useful.
Earlier Information Can Change the Conversation
One of the biggest advantages of earlier information is not simply knowing more about the disease. It is having more time to make decisions while the person living with Alzheimer’s can still participate meaningfully in them.
This can include conversations about treatment, future care preferences, finances, living arrangements, transportation, safety, and the roles different family members may play, these conversations can be difficult, but they become much harder when they are postponed until a crisis forces the family to make decisions quickly.
The growing role of blood-based biomarkers illustrates this shift. Research supported by the National Institute on Aging has shown significant progress in blood tests measuring phosphorylated tau, including p-tau217, while clinical use continues to develop and requires appropriate interpretation alongside other information.
Earlier information does not remove uncertainty. It gives families more time to work with it.
Technology Should Support the Person, Not Just Measure Them
The value of technology in Alzheimer’s care is often described in terms of monitoring: tracking movement, sleep, medication, or other changes.
Monitoring can be useful, but measurement alone isn't the goal.
The more important question is what happens with the information once it is collected. If a change in routine or behavior is detected, can it help a caregiver understand what the person needs? Can it help a clinician have a more informed conversation? Can it reduce unnecessary administrative work or make it easier to coordinate care?
Research into health information technology for Alzheimer’s and related dementias is increasingly focused on these broader questions, including how telehealth and digital tools affect access, quality, coordination, and disparities in care.
The best technology should reduce friction rather than create another system for families to manage. It should support independence where possible and make human care more informed, not less human.
The Caregiver Is Part of the Care Plan
There is another part of Alzheimer’s care that cannot be overlooked: the person providing it.
Caregiving can require significant time and effort, and the National Institute on Aging emphasizes that the demands of dementia care often exceed what one person can provide alone. Support can include home care, respite services, community resources, education, and other forms of assistance.
That makes caregiver support more than an optional addition to the care plan. It is part of building a sustainable one.
Technology can help by making information easier to access, supporting remote communication with care teams, reducing administrative tasks, or giving caregivers practical guidance when a new challenge appears. NIA-supported research is already examining digital and telehealth interventions designed to support dementia care partners and reduce caregiver strain.
The goal should not be to replace the caregiver with technology. It should be to give the caregiver more capacity to focus on the person rather than spending all of their energy managing the logistics surrounding the disease.
Care Is Becoming More Continuous
Another important shift is that Alzheimer’s treatment and care are no longer confined to a single appointment or location.
Treatment options have expanded, and the practical demands surrounding them are becoming more complex. For example, the FDA approved a new subcutaneous starting regimen for lecanemab in 2026 that allows treatment to begin at home, either independently or with caregiver support. At the same time, the FDA has emphasized the importance of appropriate monitoring for potential treatment-related risks.
Developments like these make coordination increasingly important. Medical care, monitoring, family support, and everyday life cannot always operate as separate systems.
A more connected model allows information from different parts of the care experience to inform the next decision. That does not mean every family needs sophisticated technology. It means the overall care system should be designed around the person's needs rather than around disconnected services.
Prevention Starts With Preparation
There is an important distinction between preventing Alzheimer’s disease and preventing avoidable crises within the experience of living with it.
We do not yet have a way to prevent every case of Alzheimer’s, and there is no cure. But families can prepare earlier, clinicians can gather better information, and care teams can identify support needs before they become emergencies.
That is where the future of Alzheimer’s care becomes especially meaningful.
The goal is not to turn every aspect of aging into a data problem. It is to use better information to protect what matters: autonomy, dignity, relationships, and the ability to make thoughtful decisions before circumstances make those decisions for us.
Technology will continue to evolve, but the most valuable progress may be simpler than that.
It is giving people more useful information, earlier in the journey, and using that information to create better care before a crisis demands it.
That is what a more proactive model of Alzheimer’s care can offer: not certainty about what comes next, but more time and more choices to prepare for it. Additional Resources | Alzheimer's Association | National Institute of Aging